(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-0.71% € 1.390
Live Chart Being Loaded With Signals
Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure...
Stats | |
---|---|
Volumen de hoy | 45 796.00 |
Volumen promedio | 104 221 |
Capitalización de mercado | 42.04M |
EPS | €0 ( 2023-02-09 ) |
Próxima fecha de ganancias | ( €0 ) 2024-05-23 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -1.050 |
ATR14 | €0.0110 (0.79%) |
Sequana Medical NV Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sequana Medical NV Finanzas
Annual | 2023 |
Ingresos: | €712 000 |
Beneficio Bruto: | €-4.15M (-583.43 %) |
EPS: | €-1.220 |
FY | 2023 |
Ingresos: | €712 000 |
Beneficio Bruto: | €-4.15M (-583.43 %) |
EPS: | €-1.220 |
FY | 2022 |
Ingresos: | €922 687 |
Beneficio Bruto: | €718 090 (77.83 %) |
EPS: | €-1.350 |
FY | 2021 |
Ingresos: | €370 500 |
Beneficio Bruto: | €293 837 (79.31 %) |
EPS: | €-0.751 |
Financial Reports:
No articles found.
Sequana Medical NV
Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico